AbbVie Biotech Ventures

Suggest edits

Follow us

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 13

Portfolio

Portfolio Tracker

Add info

Add round

23 Apr 2020

$63,000,000

Venture capital (Series B)

Atlas Venture, EcoR1 Capital, GV, +5

Accent Therapeutics Completes $63M Series B Financing

FinSMEs

10 Aug 2018

£65,000,000

Venture capital (Series B)

Novartis Venture Fund, Life Sciences Partners, IP Group Plc, +7

14 Dec 2017

$50,000,000

Venture capital (Series A)

Avalon Ventures, Polaris Partners, Versant Ventures, +2

04 Oct 2017

$48,000,000

Venture capital (Series A)

SR One, AbbVie Biotech Ventures, Pfizer Venture Investments, +5

Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug

Xconomy

27 Sep 2017

$20,000,000

Venture capital (Series D)

AbbVie Biotech Ventures, Eric Lefkofsky, Craig Mundie, +4

19 Sep 2017

$30,000,000

Venture capital (Series A)

Atlas Venture, AbbVie Biotech Ventures, Lightstone Ventures

25 Jul 2017

$5,900,000

Venture capital (Series A)

ARCH Venture Partners, WRF Capital, Johnson & Johnson Innovation, +6

Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

businesswire

24 Jul 2017

$38,600,000

Venture capital (Series C)

SR One, Novartis Venture Fund, U.S. Venture Partners (USVP), +9

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Xconomy

12 Dec 2016

$7,000,000

Venture capital (Series A)

Alexandria Venture, ARCH Venture Partners, WRF Capital, +6

ApoGen Biotechnologies Raises $7M in Series A Funding

FinSMEs

30 Jun 2016

$51,500,000

Venture capital (Series A)

Polaris Partners, SR One, Omega Funds, +5

23 Apr 2014

$22,500,000

Venture capital (Series B)

Polaris Partners, Lux Capital, Third Rock Ventures, +3

14 May 2013

$70,000,000

Private equity

AbbVie Biotech Ventures, AbbVie

Index

By TNW